NO970963L - Ortosubstituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene - Google Patents

Ortosubstituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene

Info

Publication number
NO970963L
NO970963L NO970963A NO970963A NO970963L NO 970963 L NO970963 L NO 970963L NO 970963 A NO970963 A NO 970963A NO 970963 A NO970963 A NO 970963A NO 970963 L NO970963 L NO 970963L
Authority
NO
Norway
Prior art keywords
ortho
diagnostic
drug
compounds
preparation
Prior art date
Application number
NO970963A
Other languages
English (en)
Other versions
NO308793B1 (no
NO970963D0 (no
Inventor
Udo Albus
Joachim Brendel
Heinz-Werner Kleemann
Hans Jochen Lang
Wolfgang Scholz
Jan-Robert Schwark
Andreas Weichert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO970963D0 publication Critical patent/NO970963D0/no
Publication of NO970963L publication Critical patent/NO970963L/no
Publication of NO308793B1 publication Critical patent/NO308793B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Surgery (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO970963A 1996-03-04 1997-03-03 Ortosubstituerte benzoylguanidiner, deres anvendelse for fremstilling av medikamenter samt legemidler inneholdende forbindelsene NO308793B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19608161A DE19608161A1 (de) 1996-03-04 1996-03-04 Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (3)

Publication Number Publication Date
NO970963D0 NO970963D0 (no) 1997-03-03
NO970963L true NO970963L (no) 1997-09-05
NO308793B1 NO308793B1 (no) 2000-10-30

Family

ID=7787087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970963A NO308793B1 (no) 1996-03-04 1997-03-03 Ortosubstituerte benzoylguanidiner, deres anvendelse for fremstilling av medikamenter samt legemidler inneholdende forbindelsene

Country Status (30)

Country Link
US (1) US6262123B1 (no)
EP (1) EP0794172B1 (no)
JP (1) JP4039586B2 (no)
KR (1) KR970065511A (no)
CN (1) CN1071318C (no)
AR (1) AR006051A1 (no)
AT (1) ATE207462T1 (no)
AU (1) AU707619B2 (no)
BR (1) BR9701159A (no)
CA (1) CA2198980A1 (no)
CZ (1) CZ293144B6 (no)
DE (2) DE19608161A1 (no)
DK (1) DK0794172T3 (no)
ES (1) ES2166481T3 (no)
HR (1) HRP970125B1 (no)
HU (1) HUP9700542A3 (no)
ID (1) ID16106A (no)
IL (1) IL120358A (no)
MX (1) MX9701619A (no)
MY (1) MY116861A (no)
NO (1) NO308793B1 (no)
NZ (1) NZ314325A (no)
PL (1) PL185751B1 (no)
PT (1) PT794172E (no)
RU (1) RU2212400C2 (no)
SI (1) SI0794172T1 (no)
SK (1) SK283934B6 (no)
TR (1) TR199700131A2 (no)
TW (1) TW440558B (no)
ZA (1) ZA971815B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10001879A1 (de) * 2000-01-19 2001-07-19 Aventis Pharma Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CN100371328C (zh) * 2006-01-19 2008-02-27 中国药科大学 取代苯甲酰基胍衍生物、其制备方法及其医药用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW250477B (no) 1992-12-15 1995-07-01 Hoechst Ag
DK0612723T3 (da) 1993-02-20 1998-03-30 Hoechst Ag Substituerede benzoylguanidiner, fremgangsmåde til fremstilling, deres anvendelse som lægemiddel, som inhibitor af den cellulære Na+/H+-udbytning eller som diagnostikum samt lægemiddel med indhold deraf
DE4318756A1 (de) 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4404183A1 (de) * 1994-02-10 1995-08-17 Merck Patent Gmbh 4-Amino-1-piperidylbenzoylguanidine
DE4417004A1 (de) 1994-05-13 1995-11-16 Hoechst Ag Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421495A1 (de) * 1994-06-20 1995-12-21 Merck Patent Gmbh Heterocyclyloxy-benzoylguanidine
DE4430213A1 (de) * 1994-08-28 1996-02-29 Merck Patent Gmbh Arylbenzoylguanidine
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19517848A1 (de) * 1995-05-16 1996-11-21 Merck Patent Gmbh Fluorhaltige Benzoylguanidine
DE19531138A1 (de) * 1995-08-24 1997-02-27 Merck Patent Gmbh Alkenyl-benzoylguanidin-Derivate
DE19624178A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
JPH107644A (ja) 1998-01-13
KR970065511A (ko) 1997-10-13
ZA971815B (en) 1997-09-04
EP0794172A1 (de) 1997-09-10
IL120358A (en) 2002-04-21
HUP9700542A1 (en) 1997-12-29
HUP9700542A3 (en) 1998-01-28
HU9700542D0 (en) 1997-04-28
NZ314325A (en) 1998-02-26
DE59705019D1 (de) 2001-11-29
HRP970125A2 (en) 1998-04-30
TW440558B (en) 2001-06-16
HRP970125B1 (en) 2002-06-30
CN1071318C (zh) 2001-09-19
MX9701619A (es) 1998-04-30
DK0794172T3 (da) 2002-02-11
SK283934B6 (sk) 2004-05-04
PT794172E (pt) 2002-02-28
JP4039586B2 (ja) 2008-01-30
CA2198980A1 (en) 1997-09-04
DE19608161A1 (de) 1997-09-11
NO308793B1 (no) 2000-10-30
BR9701159A (pt) 1998-12-15
ES2166481T3 (es) 2002-04-16
CN1160042A (zh) 1997-09-24
SI0794172T1 (en) 2002-10-31
TR199700131A2 (tr) 1997-09-21
AU707619B2 (en) 1999-07-15
PL185751B1 (pl) 2003-07-31
SK27697A3 (en) 1997-11-05
MY116861A (en) 2004-04-30
US6262123B1 (en) 2001-07-17
CZ65497A3 (cs) 1998-05-13
CZ293144B6 (cs) 2004-02-18
IL120358A0 (en) 1997-07-13
PL318415A1 (en) 1997-09-15
AU1499797A (en) 1997-09-11
ID16106A (id) 1997-09-04
AR006051A1 (es) 1999-07-21
RU2212400C2 (ru) 2003-09-20
EP0794172B1 (de) 2001-10-24
ATE207462T1 (de) 2001-11-15
NO970963D0 (no) 1997-03-03

Similar Documents

Publication Publication Date Title
NO964639L (no) Substituerte sulfonimidamider, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
DK0825178T3 (da) Phenylsubstituerede alkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
NO972211D0 (no) Sulfonamid-substituerte kromaner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende kromanene
NO960364D0 (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO972433D0 (no) Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO964053D0 (no) Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO960627L (no) Substituerte benzolsulfonylurinstoffer, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt legemidler inneholdende dem
NO972527L (no) Orto-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende benzoylguanidinene
NO952596D0 (no) Orto-aminosubstituerte benzoylguandiner, fremgangsmåter for deres fremstilling, deres anvendelse som legemiddel eller diagnostikum såvel som medikamenter som inneholder dem
DK0754680T3 (da) 4-Fluoralkyl-substituerede benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
NO954739D0 (no) Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene
NO972793L (no) Orto-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO972434D0 (no) Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO964812D0 (no) Sulfonylamino-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
DK401988D0 (da) 11-substituerede 5-aryl-5h,11h-pyrrolo(2,1-c)-(1,4)benzoxazepiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO970963D0 (no) Ortosubstituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO970697L (no) Substituerte tiofenalkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsene
NO972406D0 (no) Bis-orto-substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO973486D0 (no) Substituerte indanylidinacetylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikamenter eller diagnostikum og medikamenter inneholdende forbindelsene
NO970798D0 (no) Ortosubstituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO983577L (no) Sulfonamidsubstituerte forbindelser, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament eller diagnostikum, samt medikament inneholdende forbindelsen
NO970964D0 (no) Ortosubstituerte benzoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO981446D0 (no) Orto-substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, anvendelse som medikament eller diagnostikum samt medikament derav
NO980564D0 (no) Sulfonamid-substituerte forbindelser, fremgangsmåte for fremstilling, anvendelse som medikament eller diagnostikum samt oppnådd medikament er beskrevet
DK225189A (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler